Skip to main content
TipRanks
Go Ultimate75% OFF

Alaunos Therapeutics (WEK0) Q2 2021 Earnings Report

0 Followers

DE:WEK0 Q2 2021 EPS Results

Actual EPS
-EUR 14.91
Consensus EPS
-EUR 15.90
Beat/Miss
Beat by +EUR 0.98
One Year Ago EPS
-EUR 12.20

DE:WEK0 Q2 2021 Revenue Results

Actual Revenue
EUR 0
Expected Revenue
EUR 0
Beat/Miss
Met expectations
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2021
Date
08/09/2021
Time
After Close
Conference Call
Monday, August 9, 2021

Q2 2021 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2021 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2021 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:WEK0 Earnings History

DE:WEK0 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 07, 20242024 (Q3)―-0.64-5.4288.27% (+4.79)
Aug 08, 20242024 (Q2)―-0.64-5.4288.25% (+4.79)
May 09, 20242024 (Q1)―-0.09-0.5482.50% (+0.45)
Mar 05, 20242023 (Q4)-0.41-0.44-0.5418.33% (+0.10)
Nov 14, 20232023 (Q3)-4.75-5.42-5.420.00% (+0.00)
Aug 14, 20232023 (Q2)-5.77-5.42-6.7820.00% (+1.36)
May 10, 20232023 (Q1)-5.73-5.42-6.7820.00% (+1.36)
Mar 07, 20232022 (Q4)-7.05-5.42-6.7820.00% (+1.36)
Nov 14, 20222022 (Q3)-6.97-5.42-14.9163.64% (+9.49)
Aug 15, 20222022 (Q2)-6.51-6.78-14.9154.55% (+8.14)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed